Inhaled nitric oxide market thrives on neonatal expansions, portable system breakthroughs, and precise dosing innovations.

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

Joe DiMaggio Children's Hospital is proud to announce a significant expansion of its Heart Institute, solidifying its position as Florida's leader in pediatric cardiac care. The addition of 14 ...

Education reporter Megan Mallicoat shares the latest on a triple-digit settlement in a case involving allegations of sexual ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Unicef warns of a catastrophic situation as at least 74 children killed in first week of 2025, with more dying from cold and starvation. • At least 74 children were killed in Gaza during the first ...

After 50 years of life, people who were born preterm had lower odds for some cardiovascular outcomes and similar odds for ...

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...

Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...